Which Myeloma Patients Could Benefit From Anti-BCMA Trials?

Multiple myeloma expert Dr. Sikander Ailawadhi discusses the DREAMM study that is investigating the use of anti-BCMA antibody-drug conjugates for myeloma treatment. Watch to learn how patients can find out if they qualify for this therapy.

Read the full article here

Related Articles